Reply Letter to "Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes"

Neurogastroenterol Motil. 2021 Jan;33(1):e14054. doi: 10.1111/nmo.14054. Epub 2020 Dec 4.
No abstract available

Keywords: 16S metabarcoding; Gut Inflammation; SCFA; inflammatory bowel disease; prebiotics.

Publication types

  • Letter
  • Comment

MeSH terms

  • Butyric Acid
  • Colitis*
  • Gastrointestinal Microbiome*
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Microbiota*

Substances

  • Butyric Acid